Stay updated on Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page.

Latest updates to the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page
- Check3 days agoChange DetectedThe POLEM trial record is displayed with its study design, eligibility criteria, interventions, and outcomes. It reports that recruitment stopped after 30 of 402 planned participants were enrolled and the study is no longer recruiting.SummaryDifference47%

- Check10 days agoChange DetectedThe site revision indicator changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide NIH notice announces the transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now displays a 403 Forbidden error, and the detailed study content and navigation previously visible on this screen appear to have been removed, leaving only the error notice.SummaryDifference18%

- Check59 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing Revision: v3.6.6 in the revision history. This indicates an updated page revision rather than a substantive change to study information.SummaryDifference0.1%

Stay in the know with updates to Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page.